chr19-17448225-C-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001190844.2(TMEM221):c.238G>C(p.Val80Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,363,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001190844.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TMEM221 | ENST00000341130.6  | c.238G>C | p.Val80Leu | missense_variant | Exon 1 of 3 | 2 | NM_001190844.2 | ENSP00000342162.5 | ||
| ENSG00000269035 | ENST00000594663.1  | c.276-2941G>C | intron_variant | Intron 2 of 3 | 3 | ENSP00000472415.1 | ||||
| TMEM221 | ENST00000593461.1  | n.85G>C | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
| ENSG00000295860 | ENST00000733255.1  | n.119+14C>G | intron_variant | Intron 1 of 4 | 
Frequencies
GnomAD3 genomes   AF:  0.000336  AC: 51AN: 151702Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.000246  AC: 8AN: 32522 AF XY:  0.000247   show subpopulations 
GnomAD4 exome  AF:  0.0000965  AC: 117AN: 1211902Hom.:  0  Cov.: 28 AF XY:  0.000109  AC XY: 65AN XY: 593704 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.000356  AC: 54AN: 151810Hom.:  0  Cov.: 32 AF XY:  0.000377  AC XY: 28AN XY: 74204 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.238G>C (p.V80L) alteration is located in exon 1 (coding exon 1) of the TMEM221 gene. This alteration results from a G to C substitution at nucleotide position 238, causing the valine (V) at amino acid position 80 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at